Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide in Women With Previously Treated Metastatic Triple Negative Cancers
NCT03709446Phase 2Completed
- Start
- Apr 2019
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflunomide in triple-negative breast cancer (TNBC), breast cancer. Started Apr 2019; status: completed.
02
Drugs
leflunomide
03
Conditions
triple-negative breast cancer (TNBC)breast cancer
Beyond the preview
Go deeper on NCT03709446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03709446.